Anden, N. E., Corrodi, H., Fuxe, K.: Turnover studies using synthesis inhibition. In: Metabolism of amines in the brain, G. Hopper, ed., pp. 38–47. New York: Macmillan 1969
Angrist, B. M., Gershon, S.: The phenomenology of experimentally-induced amphetamine psychosis: Preliminary observations. Biol. Psychiat. 2, 95–107 (1970)
Angrist, B. M., Sathananthan, G. S., Gershon, S.: Behavioral effects of l-Dopa in schizophrenic patients. Psychopharmacologia (Berl.) 31, 1–12 (1973)
Chase, T. N.: Clinical studies of dopaminergic mechanisms. In: Neuropsychopharmacology of monoamines and their regulatory enzymes, E. Usdin, ed., pp. 427–434. New York: Raven Press 1974
Chase, T. N., Shoulson, I.: Dopaminergic mechanisms in patients with extrapyramidal disease. In: Advances in neurology, Vol. 9, D. B. Calne, T. N. Chase, and A. Barbeau, eds., pp. 359–366. New York: Raven Press 1975
Connell, P. H.: Amphetamine psychosis, Maudsley Monographs, No. 5, Oxford: University Press 1958
Corrodi, H., Fuxe, K., Ungerstedt, U.: Evidence for a new type of dopamine receptor stimulating agent. J. Pharm. Pharmacol. 23, 989–991 (1971)
Costall, B., Naylor, R. J.: Is there a relationship between the involvement of extrapyramidal and mesolimbic brain areas with the cataleptic action of neuroleptic agents and their clinical effect? Psychopharmacologia (Berl.) 32, 161–170 (1973a)
Costall, B., Naylor, R. J.: On the mode of action of apomorphine. Europ. J. Pharmacol. 21, 350–361 (1973b)
Cotzias, G. C.: Levodopa, manganese and degenerations of the brain, harvey society lectures. Delivered 1972 under the auspices of the Harvey Society Series 68, pp. 115–147 New York: Academic Press 1974
Creese, I.: Behavioral evidence of dopamine receptor stimulation by piribedil (ET-495) and its metabolite S 584. Europ. J. Pharmacol. 28, 55–58 (1974)
Davis, J. M., Janowsky, D. S.: Amphetamine and methylphenidate psychosis. In: Frontiers in catecholamine research, pp. 977–981. London: Pergamon Press 1973
Duby, S. E., Cotzias, G. C., Papavasiliou, P. S., Lawrence, W. H.: Injected apomorphine and orally administered levodopa in Parkinsonism. Arch. Neurol. (Chic.) 27, 474–480 (1972)
Dunkley, B., Sanghvi, I., Friedman, E., Gershon, S.: Comparison of behavioral and cardiovascular effects of l-Dopa and 5-HTP in conscious dogs. Psychopharmacologia (Berl.) 26, 161–172 (1972)
Ellinwood, E. H., Jr., Sudilowsky, A., Nelson, L.: Behavioral analysis of chronic amphetamine intoxication. Biol. Psychiat. 4, 215–230 (1972)
Ernst, A. M.: Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacologia (Berl.) 10, 316–323 (1967)
Everett, G. M., Borcherding, J. W.: l-Dopa: Effect on concentration of dopamine, norepinephrine, and serotonin in brains of mice. Science 168, 849–850 (1970)
Friedman, E., Gershon, S.: l-Dopa: Centrally mediated emission of seminal fluid in male rats. Life Sci. 11, 435–440 (1972)
Fuxe, K., Agnate, L. F., Corrodi, H., Everitt, B. J., Hokfelt, T., Lofström, J., Ungerstedt, U.: Action of dopamine receptor agonists in forebrain and hypothalamus: Rotational behavior, ovulation and dopamine turnover. In: Advances in neurology, Vol. 9, D. B. Calne, T. N. Chase, and A. Barbeau, eds., pp. 223–242. New York: Raven Press 1975
Garrattini, S., Barreggi, S., Marc, V., Calderini, G., Marsella, P. L.: Effects of piribedil on noradrenaline and MOPEGSO4 levels in the rat brain. Europ. J. Pharmacol. 28, 214–216 (1974)
Goldberg, L. I.: Comparison of putative dopamine receptors in blood vessels and the central nervous system. In: Advances in neurology, Vol. 9, D. B. Calne, T. N. Chase, and A. Barbeau, eds., pp. 53–56. New York: Raven Press 1975
Goldstein, M., Battista, A. F., Ohmoto, T., Anagnoste, B., Fuxe, K.: Tremor and involuntary movements in monkeys: Effects of l-Dopa and of a dopamine receptor stimulating agent. Science 179, 816–817 (1973)
Griffeth, J. J., Cavanaugh, J., Oates, J.: Psychosis induced by the administration of d-amphetamine to human volunteers. In: Psychotomimetic drugs, D. H. Efron, ed., pp. 287–294. New York: Raven Press 1970
Janowsky, D. S., Davis J. M.: Dopamine, psychomotor stimulants and schizophrenia: Effects of methylphenidate and the stereoisomers of amphetamine in schizophrenics. In: Neuropsychopharmacology of monoamines and their regulatory enzymes, E. Usdin, ed., pp. 317–323. New York: Raven Press 1974
Karobath, M., Diaz, J.-L., Huttunen, M. O.: The effect of l-Dopa on the concentrations of tryptophan, tyrosine, and serotonin in rat brain. Europ. J. Pharmacol. 4, 393–396 (1971)
Leiberman, A., Le Brun, Y., Dinkar, B., Zolfaghari, M.: The use of a dopaminergic receptor stimulating agent (Piribedil, ET-495) in Parkinson's disease. In: Neuropsychopharmacology of monoamines and their regulatory enzymes, E. Usdin, ed., pp. 415–425. New York: Raven Press 1974
Lewander, T.: Effect of chronic-treatment with central stimulants on brain monoamines and some behavioral and physiological functions in rats, guinea pigs and rabbits. In: Neuropsychopharmacology of monoamines and their regulatory enzymes, E. Usdin, ed., pp. 221–239. New York: Raven Press 1974
Maj, J., Pawlowski, L.: The hypothermic effect of l-Dopa in the rat. Life Sci. 13, 141–149 (1973)
Nymark, M.: Apomorphine provoked stereotypy in the dog. Psychopharmacologia (Berl.) 26, 361–368 (1972)
Randrup, A., Munkvad, I.: Stereotyped activities produced by amphetamine in several animal species and man. Psychopharmacologia (Berl.) 11, 300–310 (1967).
Rotrosen, J., Wallach, M. B., Angrist, B., Gershon, S.: Antagonism of apomorphine induced stereotypy and emesis in dogs by thioridazine, haloperidol, and pimozide. Psychopharmacologia (Berl.) 26, 185–194 (1972)
Sathananthan, G., Angrist, B. M., Gershon, S.: Response threshold to l-Dopa in psychiatric patients. Biol. Psychiat. 7, 139–146 (1973)
Schwab, R. S., Amador, L. V., Lettvin, J. Y.: Apomorphine in Parkinson's disease. Trans. Amer. neurol. Ass. 76, 251–263 (1951)
Snyder, S. H.: Amphetamine psychosis: A “model” schizophrenia mediated by catecholamines. Amer. J. Psychiat. 130, 61–67 (1973)
Strian, F., Michler, E., Benkert, O.: Tremor inhibition in Parkinson syndrome after apomorphine administration under l-Dopa and decarboxylase inhibitor basic therapy. Pharmakopsychiat. 5, 198–205 (1972)
Ungerstedt, U.: Postsynaptic supersensitivity after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine system. Acta physiol scand., Suppl. 367, 69–93 (1971)
Van Beek, M. C., Timmerman, H.: Some benzhydryl derivatives as central dopamine receptor stimulating agents. J. Pharm. Pharmacol. 26, 57–58 (1974)
Walters, J., Bunney, B. S., Roth, R. H.: Piribedil and apomorphine: Pre- and postsynaptic effects on dopamine synthesis and neuronal activity. In: Advances in neurology, Vol. 9, D. B. Calne, T. N. Chase, and A. Barbeau, eds., pp. 273–284. New York: Raven Press 1975
Willner, J. H., Samach, M., Angrist, B. M., Wallach, M. B., Gershon, S.: Drug induced stereotyped behavior and its antagonism in dogs. Commun. Behav. Biol. 5, 135–141 (1970)
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.4